These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 27502603

  • 1. Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?
    Khalifa J, Tensaouti F, Lotterie JA, Catalaa I, Chaltiel L, Benouaich-Amiel A, Gomez-Roca C, Noël G, Truc G, Péran P, Berry I, Sunyach MP, Charissoux M, Johnson C, Cohen-Jonathan Moyal E, Laprie A.
    J Neurooncol; 2016 Oct; 130(1):181-192. PubMed ID: 27502603
    [Abstract] [Full Text] [Related]

  • 2. Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial.
    Liu ZC, Yan LF, Hu YC, Sun YZ, Tian Q, Nan HY, Yu Y, Sun Q, Wang W, Cui GB.
    BMC Med Imaging; 2017 Feb 01; 17(1):10. PubMed ID: 28143434
    [Abstract] [Full Text] [Related]

  • 3. Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation.
    Khalifa J, Tensaouti F, Chaltiel L, Lotterie JA, Catalaa I, Sunyach MP, Ibarrola D, Noël G, Truc G, Walker P, Magné N, Charissoux M, Ken S, Peran P, Berry I, Moyal EC, Laprie A.
    Eur Radiol; 2016 Nov 01; 26(11):4194-4203. PubMed ID: 26843012
    [Abstract] [Full Text] [Related]

  • 4. Identifying Voxels at Risk for Progression in Glioblastoma Based on Dosimetry, Physiologic and Metabolic MRI.
    Anwar M, Molinaro AM, Morin O, Chang SM, Haas-Kogan DA, Nelson SJ, Lupo JM.
    Radiat Res; 2017 Sep 01; 188(3):303-313. PubMed ID: 28723274
    [Abstract] [Full Text] [Related]

  • 5. Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I-II trial of radiotherapy/tipifarnib combination.
    Ken S, Deviers A, Filleron T, Catalaa I, Lotterie JA, Khalifa J, Lubrano V, Berry I, Péran P, Celsis P, Moyal EC, Laprie A.
    J Neurooncol; 2015 Sep 01; 124(3):465-73. PubMed ID: 26189058
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of Early Response to Anti-Angiogenic Therapy in Recurrent Glioblastoma: Amide Proton Transfer-weighted and Perfusion-weighted MRI compared with Diffusion-weighted MRI.
    Park JE, Kim HS, Park SY, Jung SC, Kim JH, Heo HY.
    Radiology; 2020 May 01; 295(2):397-406. PubMed ID: 32154775
    [No Abstract] [Full Text] [Related]

  • 11. Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients.
    Kim JY, Park JE, Jo Y, Shim WH, Nam SJ, Kim JH, Yoo RE, Choi SH, Kim HS.
    Neuro Oncol; 2019 Feb 19; 21(3):404-414. PubMed ID: 30107606
    [Abstract] [Full Text] [Related]

  • 12. Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.
    Kong Z, Yan C, Zhu R, Wang J, Wang Y, Wang Y, Wang R, Feng F, Ma W.
    Neuroimage Clin; 2018 Feb 19; 20():51-60. PubMed ID: 30069427
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.
    Deviers A, Ken S, Filleron T, Rowland B, Laruelo A, Catalaa I, Lubrano V, Celsis P, Berry I, Mogicato G, Cohen-Jonathan Moyal E, Laprie A.
    Int J Radiat Oncol Biol Phys; 2014 Oct 01; 90(2):385-93. PubMed ID: 25104068
    [Abstract] [Full Text] [Related]

  • 14. Diffusion-weighted MRI and ADC versus FET-PET and GdT1w-MRI for gross tumor volume (GTV) delineation in re-irradiation of recurrent glioblastoma.
    Popp I, Bott S, Mix M, Oehlke O, Schimek-Jasch T, Nieder C, Nestle U, Bock M, Yuh WTC, Meyer PT, Weber WA, Urbach H, Mader I, Grosu AL.
    Radiother Oncol; 2019 Jan 01; 130():121-131. PubMed ID: 30219612
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI.
    Saini J, Kumar Gupta P, Awasthi A, Pandey CM, Singh A, Patir R, Ahlawat S, Sadashiva N, Mahadevan A, Kumar Gupta R.
    Clin Radiol; 2018 Nov 01; 73(11):986.e7-986.e15. PubMed ID: 30197047
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach.
    Neska-Matuszewska M, Bladowska J, Sąsiadek M, Zimny A.
    PLoS One; 2018 Nov 01; 13(1):e0191341. PubMed ID: 29342201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.